NYC Psychiatry is now offering ZULRESSO™ (brexanolone) for postpartum depression (PPD). It is the only medication approved specifically to treat postpartum depression. The treatment consists of a 60 hour infusion delivered in a comfortable, home-like setting. Here in New York, where mom’s have been delivering in such isolated settings 2/2 COVID they’re placed at increased risk of PPD. Many new mothers are feeling overwhelmed at managing a newborn with possibly less assistance than they had planned. Now they can receive the only treatment approved for PPD specifically in a therapeutic setting.
Postpartum Depression is Treatable
You may feel as though something isn’t quite right. After all, having a baby can be one of the happiest times in one’s life. But during pregnancy and after giving birth, some women suffer from a medical condition known as postpartum depression (PPD).
PPD is one of the most common medical complications during and after pregnancy. It is important to take care of yourself because experiencing symptoms of PPD may have consequences. You should know that PPD is treatable with your doctor’s help.
You don’t have to push through it—talk to your doctor as soon as possible if you think you may have PPD.
You can Feel Better in 2.5 days with ZULRESSO.
In clinical studies, moms who took ZULRESSO experienced a greater improvement in symptoms of postpartum depression vs placebo in 2.5 days. Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment.
Because of the risk of serious harm resulting from excessive sedation or sudden loss of consciousness during treatment, ZULRESSO is only available through a restricted program called the ZULRESSO REMS, in which a healthcare provider will carefully monitor the patient at a certified healthcare facility.